Acciones Callitas Health Inc. Canadian Securities Exchange
Acciones
LILY
CA13125C1068
Biotecnología e investigación médica
Ventas 2018 | 0,75 1,03 0,69 | Ventas 2019 | 0,71 0,97 0,66 | Capitalización | 3,53 M 4,84 M 3,26 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -5 M -6,86 M -4,62 M | Resultado Neto 2019 | -1 M -1,37 M -924 mil | VE / Ventas 2018 | 4.852.616 x |
Deuda neta 2018 | 319 mil 438 mil 295 mil | Deuda neta 2019 | 848 mil 1,16 M 783 mil | VE / Ventas 2019 | 6.168.166 x |
P/E ratio 2018 |
-0,6
x | P/E ratio 2019 |
-1,97
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 72,04 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | - | 03/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/12/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+64,92 % | 62,86 mil M | |
-1,85 % | 41,38 mil M | |
+46,11 % | 40,38 mil M | |
-8,93 % | 27,64 mil M | |
+13,05 % | 26,46 mil M | |
-21,96 % | 18,9 mil M | |
+4,21 % | 12,67 mil M | |
+25,74 % | 12,27 mil M | |
+27,42 % | 12,07 mil M |